DEVELOPMENT OF PAN-FILOVIRUS THERAPEUTICS
$2,938,788N01FY2025AINIH
Microbiotix, Inc, Worcester MA
Investigators
Abstract
To support the advanced development of a promising candidate therapeutic for a virus under the Antiviral Program for Pandemics. The research and development activities to be supported will allow the candidate therapeutic product to progress through the product development pathway, and include preclinical and IND enabling development activities, chemistry optimization/development, GMP manufacturing, and clinical safety and efficacy assessment.
View original record on NIH RePORTER →